Martel F, Vetter T, Russ H, Gründemann D, Azevedo I, Koepsell H, Schömig E
Department of Pharmacology, University of Heidelberg, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):320-6. doi: 10.1007/BF00171063.
The kidneys and the liver are the principal organs for the inactivation of circulating organic cations. Recently, an organic cation transporter (OCT1) has been cloned from rat kidney. In order to answer the question whether OCT1 is involved also in hepatic uptake of organic cations, the pharmacological characteristics of organic cation transport in hepatocytes were compared to the characteristics of transiently expressed OCT1. Primary cultures of rat hepatocytes avidly accumulated the small organic cation 3H-1-methyl-4-phenylpyridinium (3H-MPP+). At equilibrium, the hepatocytes accumulated 3H-MPP+ 56-fold. Initial rates of specific 3H-MPP+ transport in hepatocytes were saturable. The half-saturating concentration was 13 mumol/l. 3H-MPP+ transport was sensitive to quinine (Ki = 0.79 mumol/l) and cyanine863 (Ki = 0.097 mumol/l). Quinine and cyanine863 are known inhibitors of type I hepatic transport of cationic drugs and of renal excretion of organic cations, respectively. To compare the functional characteristics of 3H-MPP+ transport in hepatocytes with those of OCT1, OCT1 has been heterologously expressed and characterized in a mammalian cell line (293 cells). Initial rates of 3H-MPP+ transport were saturable, the Km being 13 mumol/l. The rank order of inhibitory potencies of various inhibitors was almost identical in hepatocytes and 293 cells transiently transfected with OCT1. There was a positive correlation between the Ki's for the inhibition of 3H-MPP+ transport in isolated hepatocytes and transfected 293 cells (r = 0.85; P < 0.01; n = 8). The results indicate that OCT1 is functionally expressed not only in the kidney but also in hepatocytes where it is responsible for the transport of small organic cations which, in the past, have been classified as type I substrates.
肾脏和肝脏是使循环中的有机阳离子失活的主要器官。最近,一种有机阳离子转运体(OCT1)已从大鼠肾脏中克隆出来。为了回答OCT1是否也参与肝脏对有机阳离子的摄取这一问题,将肝细胞中有机阳离子转运的药理学特性与瞬时表达的OCT1的特性进行了比较。大鼠肝细胞原代培养物能大量摄取小有机阳离子3H-1-甲基-4-苯基吡啶鎓(3H-MPP+)。在平衡状态下,肝细胞摄取的3H-MPP+是原来的56倍。肝细胞中特异性3H-MPP+转运的初始速率是可饱和的。半饱和浓度为13μmol/L。3H-MPP+转运对奎宁(Ki = 0.79μmol/L)和花菁863(Ki = 0.097μmol/L)敏感。奎宁和花菁863分别是已知的阳离子药物I型肝脏转运和有机阳离子肾脏排泄的抑制剂。为了将肝细胞中3H-MPP+转运的功能特性与OCT1的特性进行比较,OCT1已在哺乳动物细胞系(293细胞)中进行了异源表达和特性鉴定。3H-MPP+转运的初始速率是可饱和的,Km为13μmol/L。在肝细胞和瞬时转染OCT1的293细胞中,各种抑制剂的抑制效力排序几乎相同。在分离的肝细胞和转染的293细胞中,抑制3H-MPP+转运的Ki值之间存在正相关(r = 0.85;P < 0.01;n = 8)。结果表明,OCT1不仅在肾脏中功能性表达,而且在肝细胞中也有功能性表达,在肝细胞中它负责转运过去被归类为I型底物的小有机阳离子。